12 | SPCB Stock is number 109 for the largest | danrocks | 03/20/2015 12:09:55 PM |
11 | SPCB Stock is number 246 for the largest | danrocks | 12/11/2014 2:59:39 PM |
10 | SPCB Stock is number 114 for the largest | danrocks | 12/10/2014 12:21:03 PM |
9 | SPCB Stock year to date has changed +156.06% | Jake13 | 12/09/2014 10:15:14 AM |
8 | SPCB 11.83 Supercom Ltd Stock Charts $SPCB Last | chartguy89 | 12/09/2014 9:13:37 AM |
7 | SPCB Stock is number 184 for the largest | danrocks | 12/08/2014 1:51:03 PM |
6 | SPCB Stock year to date has changed +171.65% | Jake13 | 12/06/2014 10:31:53 AM |
5 | SPCB 12.55 Supercom Ltd Stock Charts $SPCB Last | chartguy89 | 12/06/2014 9:31:49 AM |
4 | SPCB 12.56 Supercom Ltd $SPCB stock added to my | clayton | 12/05/2014 10:09:37 AM |
3 | Latest Supercom Ltd (SPCB) Headlines SuperCom | Stock_Tracker | 03/11/2014 10:50:17 AM |
2 | SPCB 5.86 Stock Charts $SPCB 1 Month Chart | chartguy89 | 03/09/2014 11:36:19 PM |
1 | SPCB Stock Charts Last: +0.08 Saturday, March 1, | chartguy89 | 03/01/2014 6:23:01 PM |
Recent Articles
- Promising Results for Rinatabart Sesutecan in Cancer Treatment
- Nuvalent Unveils Promising Insights on Neladalkib for ALK Cancer
- United Airlines Incident: Tarmac Collision at O'Hare Airport
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct
- Lead the Charge: Join the Fly-E Group Securities Lawsuit
- Investigation into MoonLake Immunotherapeutics Raises Concerns
- MoonLake Immunotherapeutics: Investors Investigate Potential Fraud